Humana Inc.
HUM
Rang in Aktien
#490
Humana Inc., a prominent health and well-being enterprise, operates across the... Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.
Aktienkurs
$413.86
Zuletzt synchronisiert: 2026-10-16
Marktkapitalisierung
$49.70B
Veränderung (1 Tag)
-4.08%
Veränderung (1 Jahr)
50.49%
Land
US
Handel Humana Inc. (HUM)
Kategorie
Healthcare
EPS für Humana Inc. (HUM)
EPS zum June 2026 TTM: $10.65
Laut den aktuellen Finanzberichten und dem Aktienkurs von Humana Inc. beträgt das aktuelle EPS des Unternehmens (TTM) $10.65. Am Ende des Jahres 2024 betrug das EPS $10.01 ein Rückgang im Vergleich zu dem EPS von 2023, das $20.09 betrug.
EPS-Verlauf von Humana Inc. von 2000 bis 2026
EPS am Ende jedes Jahres
| Jahr | EPS | ändert |
|---|---|---|
| 2026 (TTM) | $10.65 | 7.90% |
| 2025 | $9.87 | -1.40% |
| 2024 | $10.01 | -50.17% |
| 2023 | $20.09 | -9.50% |
| 2022 | $22.20 | -2.59% |
| 2021 | $22.79 | -10.52% |
| 2020 | $25.47 | 26.15% |
| 2019 | $20.19 | 64.95% |
| 2018 | $12.24 | -27.74% |
| 2017 | $16.94 | 312.17% |
| 2016 | $4.11 | -51.87% |
| 2015 | $8.54 | 14.78% |
| 2014 | $7.44 | -4.86% |
| 2013 | $7.82 | 3.30% |
| 2012 | $7.57 | -11.77% |
| 2011 | $8.58 | 30.99% |
| 2010 | $6.55 | 5.48% |
| 2009 | $6.21 | 60.47% |
| 2008 | $3.87 | -22.60% |
| 2007 | $5.00 | 68.35% |
| 2006 | $2.97 | 55.50% |
| 2005 | $1.91 | 9.14% |
| 2004 | $1.75 | 24.11% |
| 2003 | $1.41 | 65.88% |
| 2002 | $0.85 | 19.72% |
| 2001 | $0.71 | 31.48% |
| 2000 | $0.54 | 0.00% |
EPS für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | EPS | EPS-Differenz | Land |
|---|---|---|---|
| $17.52 | 64.51% |
US
|
|
| $3.83 | -64.04% |
US
|
|
| $22.50 | 111.27% |
US
|
|
| $24.25 | 127.70% |
US
|
|
| - | - |
US
|
